Drugs, Pharmaceuticals, and Therapeutics

Research Findings

Research Activities: Online Newsletter 
Summarizes study findings, including those specific or relevant to drugs, pharmaceuticals, and therapeutics

Agency Press Releases

Date	Title
6/18/08	New Spanish-language Consumer Guide Compares Oral Diabetes Medications
5/22/08	AHRQ Announces Guide to Help Patients on Coumadin®/Warfarin Therapy
1/1/08	Blacks, Hispanics and Other Groups Less Likely To Get Strong Pain Medications in Hospital Emergency Departments

News and Numbers

Date	Title
7/24/08	Antidepressant Prescriptions Climb by 16 Million
2/21/08	One in Four Disabled Seniors Use Risky or Ineffective Medicines
2/21/08	More Consumers Buying Medicines by Mail

Top of Page

Resources

Automated Telephone Reminders—New
How to Create a Pill Card—New
Is Our Pharmacy Meeting Patients' Needs? A Pharmacy Health Literacy Assessment Tool User's Guide—New
It's Your Health: Use Your Medications Safely
My Guide to Coumadin®/Warfarin Therapy
Outcomes of Pharmaceutical Outcomes Research—Impact of Studies Funded: Final Report
Outcomes of Pharmaceutical Therapy: Program Update
Prescription Drug Therapies: Reducing Costs and Improving Outcomes
Quick Tips—When Getting a Prescription
Strategies To Improve Communication Between Pharmacy Staff and Patients—New
Your Medicine: Play It Safe

Top of Page

Centers for Education and Research on Therapeutics (CERTs)

CERTs Web Site CERTs Overview: Fact Sheet—Updated

CERTs Research: Education Projects
CERTs Research: Infectious Disease
CERTs Research: Nonsteroidal Antiinflammatory Drugs (NSAIDs)
Medicaid Uses of Research from CERTs
Medicare Uses of Research from CERTs
Nominations of Topics for Research on Therapeutics
Preventable Adverse Drug Reactions: A Focus on Drug Interactions

Top of Page

Comparative Effectiveness Reviews

Comparative Effectiveness Review, No. 3:
Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Comparative Effectiveness Review, No. 4:
Comparative Effectiveness and Safety of Analgesics for Osteoarthritis
Comparative Effectiveness Review, No. 6:
Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics
Comparative Effectiveness Review, No. 7:
Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Comparative Effectiveness Review, No. 8:
Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes
Comparative Effectiveness Review, No. 10:
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
Comparative Effectiveness Review, No. 11:
Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults

Top of Page

Evidence Reports

Evidence Report/Technology Assessment, No. 3:
Pharmacotherapy for Alcohol Dependence
Evidence Report/Technology Assessment, No. 76:
Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects
Evidence Report/Technology Assessment, No. 78:
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Evidence Report/Technology Assessment, No. 82:
Pharmacologic Management of Heart Failure and Left Ventricular Systolic Dysfunction: Effect in Female, Black, and Diabetic Patients, and Cost-Effectiveness
Evidence Report/Technology Assessment, No. 97:
Pharmacological Treatment of Dementia
Evidence Report/Technology Assessment, No. 103:
Pharmacological and Surgical Treatment of Obesity
Evidence Report/Technology Assessment, No. 108:
Melatonin for Treatment of Sleep Disorders
Evidence Report/Technology Assessment, No. 135:
Management of Eating Disorders
Evidence Report/Technology Assessment, No. 156:
Antiretroviral (ARV) Drug Resistance in the Developing World

Top of Page

Medical Expenditure Panel Survey (MEPS) Reports

MEPS Chartbook, Number 16
Outpatient Prescription Drug Expenses in the U.S. Community Population, 2003 (PDF Help)
MEPS Research Findings, Number 25
Trends in the Pharmaceutical Treatment of Hypertension, 1997 to 2003 (PDF Help)
MEPS Statistical Brief, Number 58:
Chronic Conditions and Outpatient Prescription Medicines for Persons 18 and Older in the U.S. Civilian Noninstitutionalized Population, 1987 and 2001 (PDF Help)
MEPS Statistical Brief, Number 102:
Prescription Drugs: Out-of-Pocket Expenses and Unmet Need Relative to Family Income, 2002 (PDF Help)
MEPS Statistical Brief, Number 139:
Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997-2003 (PDF Help)
MEPS Statistical Brief, Number 144:
Trends in Brand Name and Generic Prescribed Medicine Utilization and Expenditures, 1999 and 2003 (PDF Help)
MEPS Statistical Brief, Number 154:
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2004 (PDF Help)
MEPS Statistical Brief, Number 158:
Prescription Drug Expenditures in the 10 Largest States for Persons under Age 65, 2004 (PDF Help)
MEPS Statistical Brief, Number 163:
Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004 (PDF Help)
MEPS Statistical Brief, Number 179:
Aspirin Use among the Adult U.S. Noninstitutionalized Population, with and without Indicators of Heart Disease, 2005 (PDF Help)

Top of Page

Meetings & Conferences

Appropriate Drug Use and Prescription Drug Programs: Adding Value by Improving Quality
Workshop Brief, November 2001
Depression: Pharmaceutical Use and Costs
Workshop Brief, July 2000

Top of Page